LRRK2 Animal Models

被引：0
|
作者：
Shen, J. [1 ]
机构：
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
MOVEMENT DISORDERS | 2010年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S594 / S594
页数：1
相关论文
共 50 条
  • [21] The synaptic function of LRRK2
    Lee, Seongsoo
    Imai, Yuzuru
    Gehrke, Stephan
    Liu, Song
    Lu, Bingwei
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2012, 40 : 1047 - 1051
  • [22] LRRK2 Therapeutic Opportunities
    Dawson, V.
    MOVEMENT DISORDERS, 2010, 25 : S594 - S595
  • [23] The GTPase function of LRRK2
    Taymans, Jean-Marc
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2012, 40 : 1063 - 1069
  • [24] LRRK2: A target for neuroprotection?
    Farrer, M. J.
    JOURNAL OF NEUROCHEMISTRY, 2008, 104 : 92 - 92
  • [25] LRRK2 mutations and Parkinsonism
    Albrecht, M
    LANCET, 2005, 365 (9466): : 1230 - 1230
  • [26] The LRRK2 signalling system
    Price, Alice
    Manzoni, Claudia
    Cookson, Mark R.
    Lewis, Patrick A.
    CELL AND TISSUE RESEARCH, 2018, 373 (01) : 39 - 50
  • [27] LRRK2 binds to membrane
    Hatano, T.
    Kubo, S.-I.
    Mizuno, Y.
    Hattori, N.
    MOVEMENT DISORDERS, 2007, 22 : S16 - S17
  • [28] Pharmacological inhibition of LRRK2 cellular phosphorylation sites provides insight into LRRK2 biology
    Zhao, Jing
    Hermanson, Spencer B.
    Carlson, Coby B.
    Riddle, Steven M.
    Vogel, Kurt W.
    Bi, Kun
    Nichols, R. Jeremy
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2012, 40 : 1158 - 1162
  • [29] Pharmacological LRRK2 kinase inhibition induces LRRK2 protein destabilization and proteasomal degradation
    Lobbestael, E.
    Civiero, L.
    De Wit, T.
    Taymans, J. -M.
    Greggio, E.
    Baekelandt, V.
    SCIENTIFIC REPORTS, 2016, 6
  • [30] Pharmacological LRRK2 kinase inhibition induces LRRK2 protein destabilization and proteasomal degradation
    E. Lobbestael
    L. Civiero
    T. De Wit
    J.-M. Taymans
    E. Greggio
    V. Baekelandt
    Scientific Reports, 6
12345